• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.79% Nasdaq Up 0.53%

    DepoMed Inc. (DEPO)

    -NasdaqGS
    20.86 Down 0.60(2.80%) Jul 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:21.46
    Open:21.70
    Bid:19.95 x 100
    Ask:N/A
    1y Target Est:27.43
    Beta:1.42
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:20.60 - 21.82
    52wk Range:9.85 - 28.16
    Volume:1,638,035
    Avg Vol (3m):1,571,890
    Market Cap:1.25B
    P/E (ttm):13.01
    EPS (ttm):1.60
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DEPODown 2.80%1.25B
    MRKUp 1.18%162.73B
    PFEUp 0.48%207.45B
    TEVAUp 3.13%51.69B

    Key Statistics

    Forward P/E (1 yr):17.38
    P/S (ttm):3.72
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.29
    Quarterly EPS Est (Jun-15) :-0.03
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):2.40

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAM... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback